Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
PETX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-0.01%139.512.8%$303.09m
ZTSZoetis, Inc. Class A
0.53%102.921.9%$188.96m
MYLMylan N.V.
0.20%19.693.2%$186.78m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-0.95%11.432.0%$173.50m
TXMDTherapeuticsMD, Inc.
0.63%3.2024.9%$12.07m
PETXAratana Therapeutics, Inc.
-1.03%4.818.5%$9.86m
TAROTaro Pharmaceutical Industries Ltd.
-0.22%101.906.4%$7.11m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
-0.53%37.822.0%$5.90m
ABEOAbeona Therapeutics, Inc.
-0.14%7.007.6%$2.65m
KINKindred Biosciences, Inc.
-0.12%8.280.3%$1.54m
LFVNLifeVantage Corporation
-1.05%11.293.3%$1.21m
JAGXJaguar Animal Health, Inc.
-3.07%0.179.8%$0.54m
CPHIChina Pharma Holdings, Inc.
-2.33%0.290.1%$0.09m

Company Profile

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.